4250 Plymouth Road, Building 16, Room G243E
Ann Arbor, MI 48109
Available to mentor
Dr. Lagisetty is a physician investigator who practices both as a primary care physician and within inpatient hospital settings. She completed medical school at the Johns Hopkins School of Medicine and went on to do her training in primary care and internal medicine at Massachusetts General Hospital. Following residency she completed a Robert Wood Johnson Clinical Scholars Fellowship in health services research and policy. Her clinical and research interests focuses on way to improve health care delivery to better manage pain and substance use disorders in primary care settings. She also leads a SAMHSA funded initiative to improve the medical school curriculum around substance use disorders and is involved with resident teaching in this area.
-
FellowshipRobert Wood Johnson Clinical Scholar, University of Michigan, 2016
-
ResidencyMassachusetts General Hospital, Department of Internal Medicine and Primary Care, 2014
-
CertificatePartners HealthCare, Health Policy Course, Graduate Medical School Education
-
Center MemberInstitute for Healthcare Policy and Innovation
Understanding how stigma and racism affect care for individuals with chronic pain and substance use disorders.
Evaluating the effects of health policy on morbidity and mortality associated with drug use.
Developing tailored behavioral and systems interventions for patients with chronic pain and substance use disorders.
-
Jaffe K, Patel S, Chen L, Slat S, Bohnert A, Lagisetty P. Subst Use Addctn J, 2024 Oct; 45 (4): 706 - 715.Journal ArticleImpact of Perceived Access and Treatment Knowledge on Medication Preferences for Opioid Use Disorder.
DOI:10.1177/29767342241254591 PMID: 38828548 -
Chua K-P, Conti RM, Lagisetty P, Bohnert ASB, Nuliyalu U, Nguyen TD. J Gen Intern Med, 2024 Sep; 39 (12): 2160 - 2168.Journal ArticleAssociation Between Cost-Sharing and Buprenorphine Prescription Abandonment.
DOI:10.1007/s11606-024-08819-2 PMID: 38888865 -
Jaffe K, Slat S, Chen L, Macleod C, Bohnert A, Lagisetty P. J Subst Use Addict Treat, 2024 Aug; 163: 209361Journal ArticlePerceptions around medications for opioid use disorder among a diverse sample of U.S. adults.
DOI:10.1016/j.josat.2024.209361 PMID: 38703949 -
2024 Jul;PresentationCurrent Treatment Practices and Access Considerations for OUD
-
Kehne A, Macleod C, Brauninger M, DiClemente J, McCall E, Preston Y, Menke N, Lagisetty P. Drug and Alcohol Dependence, 2024 Jul; 260: 110408Journal ArticleM128 Impact of an Addiction Consultation Team on the Initiation of Medication for Opioid Use Disorder and Readmissions for Patients With Substance Use Disorders
DOI:10.1016/j.drugalcdep.2023.110408 -
Lagisetty P, Kehne A, Slat S, Macleod C, Bohnert A. Drug and Alcohol Dependence, 2024 Jul; 260: 110718Journal ArticleW100 Impact of a Brief Educational Intervention on Preferences for Medications for Opioid Use Disorder
DOI:10.1016/j.drugalcdep.2023.110718 -
Chua K-P, Conti RM, Lagisetty P, Bohnert AS, He S, Nguyen TD. JAMA, 2024 Jul 9; 332 (2): 124 - 132.Journal ArticleAssociation Between Cost Sharing and Naloxone Prescription Dispensing.
DOI:10.1001/jama.2024.8378 PMID: 38869887 -
2024 Jun;PresentationExploring Barriers to Care Continuity: Stigma, Findings from a Secret Shopper Study, and Perspectives from Maine